Immunopharmacology, positioned at the intersection of immunology and pharmacology, is dedicated to shaping the immune system for therapeutic advantages. This interdisciplinary realm intricately explores the interplay between drugs and the immune system, investigating how pharmaceutical agents can enhance immune responses. Ongoing advancements continuously yield innovative immunomodulatory drugs, targeting specific pathways to address a range of conditions, from autoimmune disorders to cancer. Within immunopharmacology, there is a meticulous examination of the delicate balance between fortifying immune responses against pathogens and mitigating the adverse effects of excessive inflammation. Recognizing the immunomodulatory impacts of existing drugs becomes crucial, paving the way for repurposing medications to tackle emerging therapeutic challenges. The evolving landscape of immunopharmacology is defined by a dedicated pursuit of personalized immunotherapies, considering individual genetic variations in drug responses. As researchers unravel the intricate tapestry of the immune system, the promise of more precisely targeted and effective pharmacological interventions continues to grow.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia